Skip to main content
Profile picture for Antoni Chan, MD, PhD

Antoni Chan, MD, PhD

Prof. Antoni Chan, PhD, FRCP, is Consultant Rheumatologist, Professor and Head of Rheumatology at the Royal Berkshire NHS Foundation Trust, Reading, United Kingdom. He is a also a specialist physician with a broad interest in internal medicine. He has been on the faculty of RheumNow since 2019. His specialist area of research is in spondyloarthropathies and digital healthcare technologies including artificial intelligence. He is a full member of ASAS and GRAPPA. He is on the working group of the British Society for Rheumatology (BSR) axSpA biologics guideline group. He won the BSR Best Practice Award in 2016 and 2024 for an innovative pain management and primary care educational programme. In 2018 he received the Patient Choice Award for Best Care by a Rheumatologist and in 2023 the Gold Changemaker Award from the National Axial Spondyloarthritis Society (NASS) UK. He leads the Axial Spondyloarthritis service in his hospital and his team have published their work on reducing delay to diagnosis in this condition. Follow him on X @synovialjoints.

Articles By Antoni Chan, MD, PhD

Advance growth

Practical use of JAK inhibitors in select groups in Axial SpA

A new treatment for AxSpA that has come on the scene are JAK inhibitors. In clinic, considerations for JAKi use are body mass index, smoking status, prior use of biologics and patients with high inflammatory states such as high CRP and inflammatory change on MRI scan of the spine and sacroiliac joints. There are further studies at #ACR22 which help answer these questions.

Read Article
Axial Spondyloarthritis

ICYMI: Update on Axial SpA at EULAR 2022

This year at EULAR 2022, there were important and interesting topics in Axial Spondyloarthritis (AxSpA). These are my picks of abstracts from the conference.

Read Article
Axial Spondyloarthritis

Update on Axial SpA at EULAR 2022

This year at EULAR 2022, there were important and interesting topics in Axial Spondyloarthritis (AxSpA). These are my picks of abstracts from the conference.

Read Article
PSA2L.jpg

Key Psoriatic Arthritis topics and updates at EULAR 2022

At EULAR 2022, I have been looking at topics and presentations in psoriatic arthritis (PsA).  Here are my top picks from this year's meeting.

Read Article
pso.PsA_.NPF_.jpg

Updates in Psoriatic Arthritis at EULAR 2022

At EULAR 2022, I look forward to key topics and presentations in psoriatic arthritis (PsA). Here's a preview of nine studies I'm particularly interested in at this meeting.

Read Article
uveitis eye iritis

New Insights into Uveitis in Spondyloarthritis

Uveitis is the most frequent extra-musculoskeletal manifestation (EAM) in Axial Spondyloarthritis (axSpA). The prevalence of uveitis in axSpA is between 25-30%. Up to 50% of patients with an acute episode of uveitis develop recurrent anterior uveitis or iritis.

Read Article
uveitis eye iritis

New Insights into Uveitis in Spondyloarthritis

Uveitis is the most frequent extra-musculoskeletal manifestation (EAM) in Axial Spondyloarthritis (axSpA). The prevalence of uveitis in axSpA is between 25-30%. Up to 50% of patients with an acute episode of uveitis develop recurrent anterior uveitis or iritis.

Read Article
Puzzle pieces

Axial spondyloarthritis with psoriasis or psoriatic spondylitis

PsA commonly affects peripheral joints. In up to a quarter of PsA patients, the spine may be involved and this is known as psoriatic spondylitis (PsSpA). An important research question is whether PsSpA and Axial Spondyloarthritis (AxSpA) with psoriasis are separate conditions or not. 

Read Article
journal book learning study meeting notes

Excited About ACR Convergence 2020

I always think of why I attend the ACR: to gain new information and knowledge and bring it back to my clinic for my patients. Here's what I'm looking forward to this year.

Read Article
Xeljanz4.jpg

Spondyloarthritis at ACR Convergence 2020

There are some really interesting poster and abstract presentations on spondyloarthritis at the ACR Convergence 2020. I’ll be covering these topics, and discussing select individual posters and abstracts during this meeting. 

Read Article
×